NCT05670613

Brief Summary

Standard formulas of PN have been developed and provided to patients. Only few randomized controlled studies compared standardized vs individualized PN. Individually tailored PN, only if standard PN solutions do not meet patient's nutritional needs. ASPEN society recommends the use computerized prescribing. Technology has enabled the incorporation of medical guidelines in CDSSs. New approach: Comparison of patient's calculated nutritional needs with commercial available solutions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
67

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 12, 2021

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 15, 2022

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 18, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 17, 2022

Completed
2 months until next milestone

First Posted

Study publicly available on registry

January 4, 2023

Completed
Last Updated

January 4, 2023

Status Verified

December 1, 2022

Enrollment Period

1 year

First QC Date

November 17, 2022

Last Update Submit

December 30, 2022

Conditions

Outcome Measures

Primary Outcomes (6)

  • Estimate of Macro and Micro Nutrient Needs for PN.

    Estimation of macro and micro nutrient needs for PN by CDSS: amino acids, carbohydrates, lipid, electrolytes, energy and fluids.

    0 months - 12 months

  • Estimate the difference between actual PN energy needs (kcal per day) and energy provided in the PN solutions available in the market (kcal per 100ml).

    Compare Ready to Use PN solutions with patient's actual nutritional energy needs in order to customize PN for optimum nutrition outcome.

    0 months - 12 months

  • Estimate the difference between actual PN needs and nutrient content of Ready to use Solution for PN available in the market.

    Compare Ready to Use PN solutions on total grams of amino acids with patient's actual nutritional needs on total grams of amino acids in order to optimize patient's PN for better nutritional outcome.

    0 months - 12 months

  • Estimate the difference between actual PN needs and nutrient content of Ready to use Solution for PN available in the market.

    Compare Ready to Use PN solutions on total grams of fat with patient's actual nutritional needs on total grams of fat in order to optimize patient's PN for better nutritional outcome.

    0 months - 12 months

  • Estimate the difference between actual PN needs and nutrient content of Ready to use Solution for PN available in the market.

    Compare Ready to Use PN solutions on total grams of carbohydrates with patient's actual nutritional needs on total grams of carbohydrates in order to optimize patient's PN for better nutritional outcome.

    0 months - 12 months

  • Difference of time spent on estimation of PN needs when conducted by hand and CDSS.

    Compare time spent for a) calculation of nutritional needs, b) prescription and c) transcription by using CDSS or made by hand.

    0 months - 12 months

Study Arms (2)

Dispense Ready to Use PN Solutions

OTHER

Dispensed to patient commercial solution.

Other: CDSS Canceling

Dispense the most effective commercial Solution calculated with the use of the CDSS

OTHER

Dispensed to patient the most effective commercial solution after the CDSS calculations.

Other: CDSS Canceling

Interventions

The use of Clinical Decision Support System in Parenteral Nutrition

Dispense Ready to Use PN SolutionsDispense the most effective commercial Solution calculated with the use of the CDSS

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Hospitalize Patients unable to be fed via gastrointestinal tract.
  • Hemodynamically stable patients.
  • PN regimen should remain the same for the first 3 days.

You may not qualify if:

  • Hemodynamically unstable.
  • Anticipated need for parenteral nutrition less than 5 days.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Iaso General Hospital

Athens, Greece

Location

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SCREENING
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Parenteral Nutrition unit, PharmD

Study Record Dates

First Submitted

November 17, 2022

First Posted

January 4, 2023

Study Start

February 12, 2021

Primary Completion

February 15, 2022

Study Completion

September 18, 2022

Last Updated

January 4, 2023

Record last verified: 2022-12

Locations